The Burden of Untreated Hepatitis C Virus Infection: A US Patients’ Perspective

被引:0
作者
Antoine C. El Khoury
Jeffrey Vietri
Girish Prajapati
机构
[1] Merck & Co.,
[2] Inc.,undefined
[3] Kantar Health,undefined
[4] AllSource PPS,undefined
来源
Digestive Diseases and Sciences | 2012年 / 57卷
关键词
Hepatitis C virus; Work impairment; Indirect costs; Direct costs; Health-related quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2995 / 3003
页数:8
相关论文
共 131 条
[1]  
Armstrong GL(2006)The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 705-S46
[2]  
Wasley A(2007)Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance J Infect Dis 196 1474-s2
[3]  
Simard EP(2002)Natural history of chronic hepatitis C Hepatology 36 S35-S295
[4]  
McQuillan GM(2007)Making it happen: managed care considerations in vanquishing hepatitis C Am J Manag Care 13 327-115
[5]  
Kuhnert WL(2002)National Institutes of Health consensus development conference: management of hepatitis C Hepatology 36 s1-866
[6]  
Alter MJ(2005)Chronic hepatitis C: an age wave of disease burden Am J Manag Care 11 S286-3031
[7]  
Wang CC(2007)Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States J Viral Hepat 14 107-389
[8]  
Krantz E(2010)Antiviral therapy for hepatitis C virus: beyond the standard of care Viruses 2 826-s127
[9]  
Klarquist J(2011)Direct medical care costs among pegylated interferon plus ribavirin-treated and untreated chronic hepatitis C patients Dig Dis Sci 56 3024-1217
[10]  
Seeff LB(2007)Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis Ann Intern Med 147 677-1206